Combination Study of Guadecitabine/ASTX727 and Pembrolizumab
Combination Study of Guadecitabine/ASTX727 and Pembrolizumab
Active, not recruiting · NCT02998567 · Registry updated 2026-05-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Combination Study of Guadecitabine/ASTX727 and Pembrolizumab | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 1 | 2026-05-12 | NCT02998567 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Astex Pharmaceuticals, Inc. | 12 |
| Institute of Cancer Research, United Kingdom | 59 |
| Merck Sharp & Dohme LLC | 650 |
| Royal Marsden NHS Foundation Trust | 89 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Royal Marsden Hospital | Sutton | United Kingdom | 10 |
| UCLH | London | United Kingdom | 1 |